Abstract: A spherical calcium silicate has d50 median particle size from 1 to 35 ?m, oil absorption from 40 to 130 mL/100 g, sphericity factor (S80) at least about 0.80, BET surface area between 10-125 m2/g, and % CaO from 0.5-20 wt-%. The spherical calcium silicate are produced by (a) continuously feeding mineral acid and alkali metal silicate into a loop reaction zone having a liquid medium stream, with at least some mineral acid and alkali metal silicate reacting to form silica product; (b) continuously recirculating the liquid medium; (c) continuously discharging a portion of liquid medium with silica product; (d) filtrating and washing the liquid medium with silica product; (e) combining the filtercake of (d) with calcium hydroxide; (f) stirring combined filter cake and calcium hydroxide for 10 min to 180 min and (g) drying. The product can be used in dentifrice compositions, food mixtures, personal care applications and liquid coatings.

Abstract: Sealing bodies comprising a first body having a top surface and a bottom surface defining a thickness thereof. An inlet conduit and an outlet conduit are in fluid communication with one or more of the top surface, the bottom surface, or a top channel formed in the top surface or a bottom channel formed in the bottom surface.

Abstract: The present disclosure may provide a radio frequency transmission device. The radio frequency transmission device may include: a radio frequency power amplifier (RFPA) configured to produce a radio frequency signal; and a transmitter coil status selection module configured to transmit the radio frequency signal to at least one of a plurality of radio frequency coils. The RFPA and the transmitter coil status selection module may be housed in a device chamber.

Abstract: The present application relates to a pyrazole-substituted cyclopentanol ester derivative and use thereof, and in particular to a compound represented by formula (I), an isomer thereof, or a pharmaceutically acceptable salt thereof.

Abstract: An apparatus, method and computer program product for query optimization in a Relational Database Management System (RDBMS), wherein an optimizer accesses a query expression repository (QER), so that the optimizer learns from previous versions of the queries to improve current and subsequent versions of the queries. The QER stores planning and execution information for QEs from the previous versions of the queries, wherein the QEs comprise table relations, intermediate results and/or final results of operations in the previous versions of the queries. The optimizer searches the QER for QEs from the query execution plans, and uses information from the QEs stored in the QER when optimizing the current and subsequent versions of the queries. The optimizer may also reuses results from the QEs stored in the QER.

Abstract: The present disclosure provides a system and method for dose modulation of an X-ray scanning. The method may include obtaining an initial scanning dose rule for scanning a target subject; determining, based on the initial scanning dose rule, a power supply control rule of a grid in an X-ray tube of the X-ray scanning; and controlling a high-voltage generator to supply power to the grid according to the power supply control rule to control an output state of tube current of the X-ray tube.

Abstract: The present disclosure provides a non-contact workpiece dimension measuring device and method, and belongs to the technical field of workpiece dimension measurement.

Abstract: The present disclosure discloses a method for controlling plasma edge fuel particle backflow by powder feedback injection, including: measuring a real-time Da value by a visible spectrum diagnostic system; in the plasma control system, filtering the measured Da value by a low-pass filter, and setting a target Da value at the same time; when an actual Da value is greater than the set target Da value, calculating an output control voltage signal; wherein the magnitude of the output voltage ultimately determines the magnitude of the lithium powder injection flow rate; converting a voltage signal input by the plasma control system into a sine wave signal by the amplitude mapping converter, and outputting same to the lithium powder injection system; and receiving the voltage signal and injecting the lithium powder into the fusion device by the lithium powder injection system; wherein the injected lithium powder adsorbs the fuel particles generated by the interaction between the plasma and the wall, so that the bac

Abstract: Disclosed are a resolution method for intent-based wireless network resource conflicts and an apparatus thereof. The method includes the following steps: periodically acquiring configured resource information about a current wireless network; pre-allocating resources required for a newly-added intent; and determining whether a pre-allocated resource configuration policy is incompatible with a resource configuration policy being executed in a current network. The apparatus includes: an interface module; a solution module; a feedback module; and a storage module. Through the relative priority of intent requirements, a bias of an implementation satisfaction degree of a network configuration policy is determined, and network resource conflicts of intent requirements with different priorities are solved.

Abstract: The present invention discloses a CXCL-BPI fusion protein that can be used for treating Gram-negative bacterial infections, a coding nucleic acid thereof, a method for expressing and preparing the same, and a use thereof in the manufacture of a pharmaceutical composition for treating Gram-negative bacterial infections. The CXCL-BPI fusion protein comprises a human ELR+CXC chemokine and a bioactive fragment of N-terminal domain of human BPI, and has the dual functions of both ELR+CXC chemokine and BPI, with ability of binding to LPS and directly killing Gram-negative bacteria, and also inducing chemotaxis and promoting phagocytes to target, bind to and phagocytize Gram-negative bacteria. The mechanism of action of the fusion protein can overcome Gram-negative bacterial drug resistance.

Abstract: An adapter includes an adapting body and a valve body. The adapting body has a first mating portion and a second mating portion, where the first mating portion is configured to mate with an injection opening of a battery cell, the second mating portion is configured to mate with a gas detection apparatus, and a gas flow passage is constructed within an adapting body. The gas flow passage runs through the first mating portion and the second mating portion, and is configured for gas to flow from the injection opening to the gas detection apparatus.

Abstract: A photoelectron spectroscopy method includes: performing photoelectron spectrum detection on a target sample to obtain an initial photoelectron spectrum; selecting spectrum data points according to the initial photoelectron spectrum to obtain a photoelectron spectrum data point sequence; performing a first model parameter update on a preset initial photoelectron spectrum fitting model according to a preset expectation-maximization algorithm and the photoelectron spectrum data point sequence to obtain a first photoelectron spectrum fitting model; acquiring a target quantum effect constraint for the target sample; performing a second model parameter update on the first photoelectron spectrum fitting model according to a preset central field approximation relation and the target quantum effect constraint to obtain a second photoelectron spectrum fitting model; and performing spectrum fitting on the photoelectron spectrum data point sequence according to the second photoelectron spectrum fitting model to obtain a

Abstract: The present application provides a compound as shown in formula (0), a pharmaceutical composition containing same, a synthesis method therefore and a use thereof. The compound of the present application can significantly reduce the integrated stress response (ISR) of cells and activate the activity of eIF2B, so that the protein in the cells tends to be synthesized normally, providing more possible drugs for ISR pathway-mediated diseases or condition eIF2B-related diseases, and/or diseases related to regulation of the activity or level of eIF2B activity or level, and regulation of the activity or level of the eIF2 pathway or ISR pathway.

Abstract: The present application provides a compound as shown in formula (0), a pharmaceutical composition containing same, a synthesis method therefore and a use thereof. The compound of the present application can significantly reduce the integrated stress response (ISR) of cells and activate the activity of eIF2B, so that the protein in the cells tends to be synthesized normally, providing more possible drugs for ISR pathway-mediated diseases or condition eIF2B-related diseases, and/or diseases related to regulation of the activity or level of eIF2B activity or level, and regulation of the activity or level of the eIF2 pathway or ISR pathway.

Abstract: A photoelectric flowmeter circuit includes a circuit power supply end. The photoelectric flowmeter circuit also includes a light-emitting element, including a first end electrically connected to the circuit power supply end and a second end electrically connected to ground. The photoelectric flowmeter circuit also includes a photosensitive triode, including a collector electrically connected to the circuit power supply end and an emitter electrically connected to the ground. The photoelectric flowmeter circuit also includes a direct current (DC) blocking circuit. The photoelectric flowmeter circuit also includes a circuit output end electrically connected to the collector of the photosensitive triode through the DC blocking circuit.

Abstract: A secure boot method. The method may be performed by a communication device. According to the method, the communication device can flexibly perform secure boot by using different cryptographic algorithms based on different security requirements, to ensure security of the communication device. The communication device may obtain external secure boot code (ESBC). The ESBC includes a code segment of a first cryptographic algorithm. After the ESBC is obtained, the communication device may perform an integrity check on the ESBC, and after the integrity check on the ESBC succeeds, verify a signature of next-level software based on the first cryptographic algorithm. When a cryptographic algorithm used by the communication device cannot meet a security requirement, the ESBC may be obtained, and the first cryptographic algorithm included in the ESBC is used to perform the secure boot, to meet the security requirement.

Abstract: In accordance with an embodiment, a network device includes a chip including a hardware encryption and decryption circuit and a one-time programmable (OTP) storage area; and a receiver configured to receive a to-be-decrypted file, where the to-be-decrypted file comprises a ciphertext. The hardware encryption and decryption circuit is configured to obtain a root key plaintext from the OTP storage area, and decrypt the ciphertext using the root key plaintext to obtain a plaintext.

Abstract: Provided are a compound of formula 0, a stereoisomer thereof, a tautomer thereof, a geometric isomer thereof, an enantiomer thereof, a diastereomer thereof, a racemate thereof, a polymorph thereof, a solvate thereof, a hydrate thereof, an N-oxide thereof, an isotopically labeled compound thereof, a metabolite thereof, an ester thereof, a prodrug thereof, and a pharmaceutically acceptable salt thereof. In formula 0, ring B is a 5- to 10-membered spiro ring or a 5- to 10-membered spiro heterocyclic ring. The 5- to 10-membered spiro ring and the 5- to 10-membered spiro heterocyclic ring are optionally substituted with 1-5 R1F. The compound can significantly weaken the integrated stress response (ISR) of cells and activate the activity of eIF2B, so that proteins in the cells tend to be synthesized normally.

Abstract: An integrity verification method includes: a first device that sends first data to a second device. The first device sends an integrity measurement baseline value corresponding to the first data to a verification server, and the second device sends an integrity measurement value corresponding to the first data to the verification server. The verification server performs integrity verification on the first data based on the integrity measurement value and the integrity measurement baseline value.

Abstract: Disclosed herein are a method of controlling a bipolar high-voltage generator and an X-ray system. The bipolar high-voltage generator is connected to a load for supplying a cathode voltage and an anode voltage to the load. The bipolar high-voltage generator includes a first transformer and a second transformer. The first transformer is provided in an output circuit of the anode voltage, and the second transformer is provided in an output circuit of the cathode voltage. The method of controlling includes: obtaining a target voltage difference of the bipolar high-voltage generator, wherein the target voltage difference is within a preset range; and adjusting a working state of at least one of the first transformer and the second transformer based on the target voltage difference. The target voltage difference is defined as a difference between an absolute value of a target anode voltage and an absolute value of a target cathode voltage output from the bipolar high-voltage generator.